1918 Influenza: the Mother of All Pandemics
Open accessThe DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.
Abstract
The "Spanish" influenza pandemic of 1918–1919, which caused ≈50 million deaths worldwide, remains an ominous warning to public health. Many questions about its origins, its unusual epidemiologic features, and the basis of its pathogenicity remain unanswered. The public health implications of the pandemic therefore remain in doubt even as we now grapple with the feared emergence of a pandemic caused by H5N1 or other virus. However, new information about the 1918 virus is emerging, for example, sequencing of the entire genome from archival autopsy tissues. But, the viral genome alone is unlikely to provide answers to some critical questions. Understanding the 1918 pandemic and its implications for future pandemics requires careful experimentation and in-depth historical analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The viruses that caused the 1957 and 1968 pandemics were descendants of the 1918 virus in which 3 (the 1957 virus) or 2 (the 1968 virus) new avian gene segments had been acquired by reassortment [21].”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The pandemic caused a “W-shaped” age-specific mortality curve, which exhibited peaks in infancy, between about 20–40 years of age, and in elderly individuals [3, 21].”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“The 1968 influenza pandemic was mild, and autopsy studies were uncommon [21].”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [21]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Staphylococcus aureus, a relatively minor cause of the 1918 fatalities, was predominant in the culture results from 1957–1958 [21, 57-61], and negative lung tissue cultures were more common, possibly as a result of the widespread administration of antibiotics [57, 58, 61].”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The 1968 influenza pandemic was mild, and autopsy studies were uncommon [21].”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [21]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic.
Johnson, N. P. A. S., & Mueller, J. (2002) · Bulletin of the History of Medicine · doi:10.1353/bhm.2002.0022 · Cited by 1,980
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J., & Wiley, D. C. (1988) · Nature · doi:10.1038/333426a0 · Cited by 1,158
Characterization of the 1918 influenza virus polymerase genes
Taubenberger, J. K., Reid, A. H., Lourens, R. M., Wang, R., Jin, G., & Fanning, T. G. (2005) · Nature · doi:10.1038/nature04230 · Cited by 1,066
Self-citationRe-emergence of fatal human influenza A subtype H5N1 disease
Peiris, J., Yu, W., Leung, C., Cheung, C., Ng, W., Nicholls, J., Ng, T., Chan, K., Lai, S., Lim, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15595-5 · Cited by 812
Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus
Taubenberger, J. K., Reid, A. H., Krafft, A. E., Bijwaard, K. E., & Fanning, T. G. (1997) · Science · doi:10.1126/science.275.5307.1793 · Cited by 715
Self-citationPandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
Simonsen, L., Clarke, M. J., Schonberger, L. B., Arden, N. H., Cox, N. J., & Fukuda, K. (1998) · Journal of Infectious Diseases · doi:10.1086/515616 · Cited by 704
Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene
Reid, A. H., Fanning, T. G., Hultin, J. V., & Taubenberger, J. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1651 · Cited by 607
Self-citation(1991) · PubMed · Cited by 520
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus
Kobasa, D., Takada, A., Shinya, K., Hatta, M., Halfmann, P., Theriault, S., Suzuki, H., Nishimura, H., Mitamura, K., Sugaya, N., et al. (2004) · Nature · doi:10.1038/nature02951 · Cited by 455
Matrosovich, M. N., Gambaryan, A. S., Teneberg, S., Piskarev, V. E., Yamnikova, S. S., Lvov, D. K., Robertson, J. S., & Karlsson, K.-A. (1997) · Virology · doi:10.1006/viro.1997.8580 · Cited by 416
Research works printed but not linked: 2
- Crosby A. America's forgotten pandemic. Cambridge (UK): Cambridge University Press;1989.
- Majde JA. Influenza: Learn from the past. ASM News. 1996;62:514.
Cited by
Items 101–200 of 1,000
Disasters: lessons from the past 105 years
Eshghi, K., & Larson, R. C. (2008) · Disaster Prevention and Management An International Journal · doi:10.1108/09653560810855883 · Cited by 157
Nickol, M. E., & Kindrachuk, J. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3750-8 · Cited by 172
Epidemics and trust: the case of the Spanish flu
Aassve, A., Alfani, G., Gandolfi, F., & Le Moglie, M. (2021) · Health Economics · doi:10.1002/hec.4218 · Cited by 156
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
Jennings, L., Monto, A. S., Chan, P. K. S., Szucs, T. D., & Nicholson, K. G. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70232-9 · Cited by 163
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Liang, J. G., Su, D., Song, T., Zeng, Y., Huang, W., Wu, J., Xu, R., Luo, P., Yang, X., Zhang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21634-1 · Cited by 157
Pollution, Infectious Disease, and Mortality: Evidence from the 1918 Spanish Influenza Pandemic
Clay, K. B., Lewis, J., & Severnini, E. (2015) · The Journal of Economic History · doi:10.1017/s002205071800058x · Cited by 172
Synthetic viruses: a new opportunity to understand and prevent viral disease
Wimmer, E., Mueller, S., Tumpey, T. M., & Taubenberger, J. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1593 · Cited by 152
Self-citationWang, W., Wu, J., Zhang, X., Hao, C., Zhao, X., Jiao, G., Shan, X., Tai, W., & Yu, G. (2017) · Scientific Reports · doi:10.1038/srep40760 · Cited by 146
Mortality burden of the 1918–1919 influenza pandemic in Europe
Ansart, S., Pelat, C., Boëlle, P., Carrat, F., Flahault, A., & Valleron, A. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00080.x · Cited by 172
Innate immune modulation by RNA viruses: emerging insights from functional genomics
Katze, M. G., Fornek, J. L., Palermo, R. E., Walters, K., & Korth, M. J. (2008) · Nature reviews. Immunology · doi:10.1038/nri2377 · Cited by 159
Hassan, I. H., Zhang, M. S., Powers, L. S., Shao, J. Q., Baltrušaitis, J., Rutkowski, D. T., Legge, K. L., & Monick, M. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284695 · Cited by 156
Domestic Pigs Have Low Susceptibility to H5N1 Highly Pathogenic Avian Influenza Viruses
Lipatov, A. S., Kwon, Y. K., Sarmento, L. V., Lager, K. M., Spackman, E., Suarez, D. L., & Swayne, D. E. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000102 · Cited by 160
Emerging Influenza D Virus Threat: What We Know so Far!
Asha, K., & Kumar, B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020192 · Cited by 141
Transport Policymaking against COVID-19 and Future Public Health Pandemics: A PASS Approach
Zhang, J. (2020) · Transport Policy · doi:10.1016/j.tranpol.2020.09.009 · Cited by 139
Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis
Shim, J. M., Kim, J., Tenson, T., Min, J.-Y., & Kainov, D. E. (2017) · Viruses · doi:10.3390/v9080223 · Cited by 145
Khorramdelazad, H., Kazemi, M. H., Najafi, A., Keykhaee, M., Emameh, R. Z., & Falak, R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104554 · Cited by 142
Krishnan, L., Ogunwole, S. M., & Cooper, L. A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2223 · Cited by 133
Dunham, E. J., Dugan, V. G., Kaser, E. K., Perkins, S. E., Brown, I. H., Holmes, E. C., & Taubenberger, J. K. (2009) · Journal of Virology · doi:10.1128/jvi.02565-08 · Cited by 149
Self-citationClinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
Gasparini, R., Amicizia, D., Lai, P. L., & Panatto, D. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.8.1.17622 · Cited by 148
ARIMA models for predicting the end of COVID-19 pandemic and the risk of second rebound
Malki, Z., Atlam, E., Ewis, A. A., Dagnew, G., Alzighaibi, A. R., Elmarhomy, G., Elhosseini, M. A., Hassanien, A. E., & Gad, I. (2020) · Neural Computing and Applications · doi:10.1007/s00521-020-05434-0 · Cited by 138
Adaptive pathways of zoonotic influenza viruses: From exposure to establishment in humans
Reperant, L. A., Kuiken, T., & Osterhaus, A. D. M. E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.049 · Cited by 143
Wani, S. U. D., Khan, N. A., Thakur, G., Gautam, S. P., Ali, M., Alam, P., Alshehri, S., Ghoneim, M. M., & Shakeel, F. (2022) · Healthcare · doi:10.3390/healthcare10040608 · Cited by 119
Jana, I. D., Kumbhakar, P., Banerjee, S., Gowda, C. C., Kedia, N., Kuila, S. K., Banerjee, S., Das, N. C., Das, A. K., Manna, I., et al. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c02713 · Cited by 134
Lemaître, M., & Carrat, F. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-162 · Cited by 148
Woo, P. C. Y., Tung, E. T. K., Chan, K., Lau, C. C. Y., Lau, S. K. P., & Yuen, K. (2010) · The Journal of Infectious Diseases · doi:10.1086/649785 · Cited by 130
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases
Pan, X., Ojcius, D. M., Gao, T., Li, Z., Pan, C., & Pan, C. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.004 · Cited by 143
Barry, J. M., Viboud, C., & Simonsen, L. (2008) · The Journal of Infectious Diseases · doi:10.1086/592454 · Cited by 126
Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.
Michaelis, M., Doerr, H. W., & Cinatl, J. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0118-5 · Cited by 127
The benefits and costs of social distancing in high- and low-income countries
Barnett-Howell, Z., Watson, O. J., & Mobarak, A. M. (2021) · Transactions of The Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traa140 · Cited by 89
Adaptation of influenza viruses to human airway receptors
Thompson, A. J., & Paulson, J. C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013309 · Cited by 134
Emerging Antiviral Strategies to Interfere with Influenza Virus Entry
Vanderlinden, E., & Naesens, L. M. J. (2013) · Medicinal Research Reviews · doi:10.1002/med.21289 · Cited by 124
Oncology Nursing During a Pandemic: Critical Reflections in the Context of COVID-19
Paterson, C., Gobel, B., Gosselin, T., Haylock, P. J., Papadopoulou, C., Slusser, K., Rodriguez, A., & Pituskin, E. (2020) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2020.151028 · Cited by 116
Glynn, J. R., & Moss, P. A. H. (2020) · Scientific Data · doi:10.1038/s41597-020-00668-y · Cited by 131
Le, T. T., Chang, P., Benton, D. J., McCauley, J. W., Iqbal, M., & Cass, A. E. G. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01149 · Cited by 126
Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality
Fischer, W. A., Gong, M. N., Bhagwanjee, S., & Sevransky, J. (2014) · Global Heart · doi:10.1016/j.gheart.2014.08.004 · Cited by 121
Kim, K., Kashefi‐Kheyrabadi, L., Joung, Y., Kim, K., Dang, H., Chavan, S. G., Lee, M., & Choo, J. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.129214 · Cited by 123
He, L., Lin, X., Wang, Y., Abraham, C., Sou, C., Ngo, T., Zhang, Y., Wilson, I. A., & Zhu, J. (2021) · Science Advances · doi:10.1126/sciadv.abf1591 · Cited by 122
Microfluidic systems for infectious disease diagnostics
Lehnert, T., & Gijs, M. A. M. (2024) · Lab on a Chip · doi:10.1039/d4lc00117f · Cited by 129
Memoli, M. J., Harvey, H. A., Morens, D. M., & Taubenberger, J. K. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12055 · Cited by 124
Self-citationWeather Variability and COVID-19 Transmission: A Review of Recent Research
McClymont, H., & Hu, W. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020396 · Cited by 118
Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries
Henry, J., Smeyne, R. J., Jang, H., Miller, B., & Okun, M. S. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.06.012 · Cited by 110
Pathogenic Responses among Young Adults during the 1918 Influenza Pandemic
Shanks, G. D., & Brundage, J. F. (2012) · Emerging infectious diseases · doi:10.3201/eid1802.102042 · Cited by 133
Host genetics of severe influenza: from mouse Mx1 to human IRF7
Ciancanelli, M. J., Abel, L., Zhang, S., & Casanova, J. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.002 · Cited by 122
The Role of Innate Leukocytes during Influenza Virus Infection
Lamichhane, P. P., & Samarasinghe, A. E. (2019) · Journal of Immunology Research · doi:10.1155/2019/8028725 · Cited by 128
Homologous Recombination Is Very Rare or Absent in Human Influenza A Virus
Boni, M. F., Zhou, Y., Taubenberger, J. K., & Holmes, E. C. (2008) · Journal of Virology · doi:10.1128/jvi.02683-07 · Cited by 135
Self-citationPandemic influenza: certain uncertainties
Morens, D. M., & Taubenberger, J. K. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.689 · Cited by 133
Self-citationEntry Inhibitors: Efficient Means to Block Viral Infection
Pattnaik, G. P., & Chakraborty, H. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00136-z · Cited by 120
Societal Impacts of Pandemics: Comparing COVID-19 With History to Focus Our Response
Patterson, G. E., McIntyre, K. M., Clough, H. E., & Rushton, J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.630449 · Cited by 137
Towards a sane and rational approach to management of Influenza H1N1 2009
Gallaher, W. R. (2009) · Virology Journal · doi:10.1186/1743-422x-6-51 · Cited by 121
Resilience in the time of pandemic: The experience of community pharmacists during COVID-19
Austin, Z., & Gregory, P. J. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.05.027 · Cited by 113
Disease, downturns, and wellbeing: Economic history and the long-run impacts of COVID-19
Arthi, V., & Parman, J. M. (2020) · Explorations in Economic History · doi:10.1016/j.eeh.2020.101381 · Cited by 128
Human influenza viruses and CD8+ T cell responses
Grant, E. J., Quiñones‐Parra, S. M., Clemens, E. B., & Kedzierska, K. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.016 · Cited by 118
Thomaston, J. L., Polizzi, N. F., Konstantinidi, A., Wang, J., Kolocouris, A., & DeGrado, W. F. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b06741 · Cited by 109
Xu, Y., & Liu, L. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12459 · Cited by 107
Novel Platforms for the Development of a Universal Influenza Vaccine
Kumar, A., Meldgaard, T. S., & Bertholet, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00600 · Cited by 115
The COVID-19 pandemic: implications for the cytology laboratory
Pambuccian, S. E. (2020) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2020.03.001 · Cited by 119
Triana‐Baltzer, G., Gubareva, L. V., Nicholls, J. M., Pearce, M. B., Mishin, V. P., Belser, J. A., Chen, L., Chan, R. W. Y., Chan, M. C. W., Hedlund, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007788 · Cited by 110
Basler, C. F., & Aguilar, P. V. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.04.006 · Cited by 118
Westgeest, K. B., de Graaf, M., Fourment, M., Bestebroer, T. M., van Beek, R., Spronken, M. I. J., de Jong, J. C., Rimmelzwaan, G. F., Russell, C. A., Osterhaus, A. D. M. E., et al. (2012) · Journal of General Virology · doi:10.1099/vir.0.043059-0 · Cited by 109
Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections
Furuya‐Kanamori, L., Cox, M. W., Milinovich, G. J., Magalhães, R. J. S., Mackay, I. M., & Yakob, L. (2016) · Emerging infectious diseases · doi:10.3201/eid2206.151080 · Cited by 111
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
Kumar, V., Tan, K.-P., Wang, Y., Lin, S., & Liang, P. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.013 · Cited by 105
Population-level effects of suppressing fever
Earn, D. J. D., Andrews, P. W., & Bolker, B. M. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2013.2570 · Cited by 109
Determinants of virulence of influenza A virus
Schrauwen, E. J. A., Graaf, M., Herfst, S., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1984-8 · Cited by 96
The evolution of human influenza A viruses from 1999 to 2006: A complete genome study
Bragstad, K., Nielsen, L. P., & Fomsgaard, A. (2008) · Virology Journal · doi:10.1186/1743-422x-5-40 · Cited by 118
Skowronski, D. M., Hottes, T. S., McElhaney, J. E., Janjua, N. Z., Sabaiduc, S., Chan, T., Gentleman, B., Purych, D., Gardy, J., Patrick, D. M., et al. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jiq039 · Cited by 100
COVID-19: Forecasting confirmed cases and deaths with a simple time series model
Petropoulos, F., Makridakis, S., & Stylianou, N. (2020) · International Journal of Forecasting · doi:10.1016/j.ijforecast.2020.11.010 · Cited by 114
The Spanish influenza pandemic in occidental Europe (1918–1920) and victim age
Barrena, A. E. (2010) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00125.x · Cited by 103
Finding the real case-fatality rate of H5N1 avian influenza
Li, F. C. K., Choi, B. C. K., Sly, T., & Pak, A. W. P. (2008) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2007.064030 · Cited by 100
Infection Fatality Risk of the Pandemic A(H1N1)2009 Virus in Hong Kong
Wong, J. Y., Wu, P., Nishiura, H., Goldstein, E., Lau, E. H. Y., Yang, L., Chuang, S. K., Tsang, T., Peiris, M. J. S., Wu, J. T. K., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws314 · Cited by 105
Beyond R 0: heterogeneity in secondary infections and probabilistic epidemic forecasting
Hébert‐Dufresne, L., Althouse, B. M., Scarpino, S. V., & Allard, A. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0393 · Cited by 109
Immunosensor-based label-free and multiplex detection of influenza viruses: State of the art
Zhang, H., & Miller, B. L. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111476 · Cited by 102
Development of effective anti-influenza drugs: congeners and conjugates – a review
Shie, J., & Fang, J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0567-0 · Cited by 105
Multiwave pandemic dynamics explained: how to tame the next wave of infectious diseases
Cacciapaglia, G., Cot, C., & Francesco Sannino, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-85875-2 · Cited by 98
Reducing antibiotic use in influenza: challenges and rewards
Low, D. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01910.x · Cited by 104
Baig, M. S., Alagumuthu, M., Rajpoot, S., & Saqib, U. (2020) · Drugs in R&D · doi:10.1007/s40268-020-00312-5 · Cited by 100
The impending storm: COVID-19, pandemics and our overwhelmed emergency departments
Mareiniss, D. P. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.03.033 · Cited by 96
Juozapaitis, M., Moreira, É. A., Mena, I., Giese, S., Riegger, D., Pohlmann, A., Höper, D. W., Zimmer, G., Beer, M., García‐Sastre, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5448 · Cited by 94
Talmi-Frank, D., Altboum, Z., Solomonov, I., Udi, Y., Jaitin, D. A., Klepfish, M., David, E., Zhuravlev, A., Keren‐Shaul, H., Winter, D. R., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.09.005 · Cited by 100
Influenza Infections and Emergent Viral Infections in Intensive Care Unit
Cantan, B., Luyt, C. E., & Martín‐Loeches, I. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693497 · Cited by 103
Hoogenboom, W. S., Pham, A., Anand, H., Fleysher, R., Buczek, A., Soby, S., Mirhaji, P., Yee, J., & Duong, T. Q. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100041 · Cited by 94
Pandemics and the emerging stock markets
Salisu, A. A., Sikiru, A. A., & Vo, X. V. (2020) · Borsa Istanbul Review · doi:10.1016/j.bir.2020.11.004 · Cited by 93
Michaelis, M., Geiler, J., Naczk, P., Sithisarn, P., Ogbomo, H., Altenbrandt, B., Leutz, A., Doerr, H. W., & Cinatl, J. J. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0155-0 · Cited by 97
Understanding influenza transmission, immunity and pandemic threats
Mathews, J. D., Chesson, J. M., McCaw, J. M., & McVernon, J. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00089.x · Cited by 98
The Shifting Demographic Landscape of Pandemic Influenza
Bansal, S., Pourbohloul, B., Hupert, N., Grenfell, B. T., & Ancel, L. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009360 · Cited by 93
Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009
Khandaker, G., Dierig, A., Rashid, H., King, C. L., Heron, L. G., & Booy, R. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00199.x · Cited by 92
Predicting ‘airborne’ influenza viruses: (trans-) mission impossible?
Sorrell, E. M., Schrauwen, E., Linster, M., de Graaf, M., Herfst, S., & Fouchier, R. A. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.07.003 · Cited by 92
Lemaître, M., Carrat, F., Rey, G., Miller, M., Simonsen, L., & Viboud, C. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045051 · Cited by 96
Strategies for Post-COVID Cities: An Insight to Paris En Commun and Milano 2020
Pisano, C. (2020) · Sustainability · doi:10.3390/su12155883 · Cited by 110
Perspectives on influenza evolution and the role of research
Forrest, H. L., & Webster, R. G. (2010) · Animal Health Research Reviews · doi:10.1017/s1466252310000071 · Cited by 102
Skowronski, D. M., Janjua, N. Z., Serres, G. D., Purych, D., Gîlca, V., Scheifele, D. W., Dionne, M., Sabaiduc, S., Gardy, J. L., Li, G., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis500 · Cited by 93
Current and Future Developments in the Treatment of Virus-Induced Hypercytokinemia
Wong, J. P., Viswanathan, S., Wang, M., Sun, L.-Q., Clark, G. C., & D’Elia, R. V. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0181 · Cited by 94
miR-21-3p Regulates Influenza A Virus Replication by Targeting Histone Deacetylase-8
Xia, B., Lu, J., Wang, R., Yang, Z., Zhou, X., & Huang, P. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00175 · Cited by 90
Epidemiology of Coronavirus COVID-19: Forecasting the Future Incidence in Different Countries
Stübinger, J., & Schneider, L. (2020) · Healthcare · doi:10.3390/healthcare8020099 · Cited by 89
Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase
Sadati, S., Gheibi, N., Ranjbar, S., & Hashemzadeh, M. S. (2018) · Biomedical Reports · doi:10.3892/br.2018.1173 · Cited by 97
Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India
Mishra, A., Chadha, M., Choudhary, M. L., & Potdar, V. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010540 · Cited by 90
The role of influenza in the severity and transmission of respiratory bacterial disease
Mina, M. J., & Klugman, K. P. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70131-6 · Cited by 77
Goto, H., Sagitani, A., Ashida, N., Kato, S., Hirota, T., Shinoda, T., & Yamamoto, N. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513001104 · Cited by 76
Nelson, R. E. (2009) · Health Economics · doi:10.1002/hec.1544 · Cited by 96
Pleguezuelos, O., Robinson, S., Stoloff, G. A., & Caparrós‐Wanderley, W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.089 · Cited by 85
Shi, P., Keskinocak, P., Swann, J., & Lee, B. Y. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-778 · Cited by 87
Metadata
- Authors
- Taubenberger, J. K., & Morens, D. M.
- Affiliations
- Armed Forces Institute of Pathology (US)
- National Institutes of Health (US)
- Corresponding author
- Taubenberger, Jeffery K.
- Venue
- Emerging Infectious Diseases
- Published
- 2006-01
- Volume
- 12
- Issue
- 1
- Pages
- 15-22
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W4292550103
- Cited by
- 1,590
- References
- 35
- Citations by year
- 2026: 42 · 2025: 46 · 2024: 55 · 2023: 94 · 2022: 124 · 2021: 206 · 2020: 212 · 2019: 61 · 2018: 73 · 2017: 59 · 2016: 67 · 2015: 51 · 2014: 51 · 2013: 50 · 2012: 67
- FWCI
- 46.04
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Sociology and Political Science › Global Security and Public Health
- Keywords
- 1918 influenza pandemic, pandemic preparedness, H5N1 avian influenza, influenza epidemiology, viral genome sequencing, history of pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.